Leading Patent Litigator Joins Latham & Watkins
By Lawdragon News | January 23, 2012 | Press Releases
Patent litigation capability further bolstered with arrival of life sciences trial lawyer, with particular expertise in Hatch-Waxman litigation, marking another step forward in the expansion of the firm’s intellectual property practice
New York, January 17, 2012 … Latham & Watkins LLP is pleased to announce that Daniel G. Brown has joined the firm’s New York office as a partner in the Litigation Department. Brown, who specializes in patent litigation involving pharmaceutical and life sciences companies, joins a team of premier IP litigators that has nearly doubled in the last two years.
Brown has a broad scope of pharmaceutical and life sciences capabilities including “Hatch-Waxman” litigation. These high-stakes patent disputes have become increasingly important to pharmaceutical companies. Brown has more than a decade of experience in this highly complex and business-critical area of litigation for prominent pharmaceutical companies at both the trial and appellate levels, including complex litigation matters that involved simultaneous antitrust litigation and litigation with the FDA.
Brown’s addition to the intellectual property litigation team follows a number of other recent high-profile additions. In the last two years, a group of six prominent intellectual property litigation partners joined the firm’s California offices and three industry leaders with extensive experience in patent litigation, joined the firm’s Washington, D.C. office, including those with expertise before the International Trade Commission (ITC).
Jimmy Brandt, Latham & Watkins’ Office Managing Partner in New York, said: “I am pleased to welcome Dan to the firm. Having Dan join the New York office will be yet another step forward in bolstering the firm’s growing intellectual property practice, and an excellent addition to our strong New York litigation team.”
“Bringing his depth of expertise in high-stakes ANDA disputes to the firm, Dan helps position Latham as a market leader in the generic pharmaceutical patent litigation segment and will permit the practice group to enhance its rapidly developing position in high-stakes patent litigation,” said Max Grant, Global Co-Chair of the firm’s Intellectual Property Litigation Practice Group. “Dan’s extensive knowledge of Hatch-Waxman litigation will be a valuable asset to our clients and to the firm, complementing both our deep bench of patent litigators and our experienced team of counselors to pharmaceutical companies.”
“I am impressed with the growth and success of Latham & Watkins’ Intellectual Property Litigation Practice Group,” said Brown. “The firm’s team-centered approach and continued focus on growing its patent litigation platform makes this an exciting opportunity for me and I look forward to contributing to the firm’s collective effort.”
Brown joins Latham & Watkins from Wilson Sonsini Goodrich & Rosati. He received his JD from University of Cincinnati College of Law in 1993 and BS degree in Chemical Engineering from the University of Houston in 1990.
